Literature DB >> 25895709

Radiation therapy for glioma stem cells.

Anthony E Rizzo1, Jennifer S Yu.   

Abstract

Radiation therapy is the most effective adjuvant treatment modality for virtually all patients with high-grade glioma. Its ability to improve patient survival has been recognized for decades. Cancer stem cells provide new insights into how tumor biology is affected by radiation and the role that this cell population can play in disease recurrence. Glioma stem cells possess a variety of intracellular mechanisms to resist and even flourish in spite of radiation, and their proliferation and maintenance appear tied to supportive stimuli from the tumor microenvironment. This chapter reviews the basis for our current use of radiation to treat high-grade gliomas, and addresses this model in the context of therapeutically resistant stem cells. We discuss the available evidence highlighting current clinical efforts to improve radiosensitivity, and newer targets worthy of further development.

Entities:  

Mesh:

Year:  2015        PMID: 25895709     DOI: 10.1007/978-3-319-16537-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.

Authors:  Wei Yang; Hongquan Yu; Yueming Shen; Yingying Liu; Zhanshan Yang; Ting Sun
Journal:  Oncotarget       Date:  2016-07-05

2.  Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis.

Authors:  Liang Gong; Jiacheng Gu; Jianwei Ge; Xiang Wu; Chao Zhang; Chun Yang; Weiji Weng; Guoyi Gao; Junfeng Feng; Qing Mao
Journal:  Onco Targets Ther       Date:  2017-12-04       Impact factor: 4.147

Review 3.  Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.

Authors:  Kshama Gupta; Terry C Burns
Journal:  Front Oncol       Date:  2018-11-08       Impact factor: 6.244

4.  Efficacy and prognosis of surgery combined with 125I seed implantation in treatment of recurrent glioma.

Authors:  Weichang Li; Ruiming Zhang; Jisheng Yang; Ruili Wang
Journal:  Oncol Lett       Date:  2017-10-04       Impact factor: 2.967

Review 5.  A molecular view of the radioresistance of gliomas.

Authors:  Xuetao Han; Xiaoying Xue; Huandi Zhou; Ge Zhang
Journal:  Oncotarget       Date:  2017-10-11

6.  IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR.

Authors:  Narui Yin; Ting Xie; Haowen Zhang; Jian Chen; Jiahua Yu; Fenju Liu
Journal:  Oncol Lett       Date:  2019-11-25       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.